Emerging Infectious Disease ISSN: 1080-6059
Volume 16, Number 5—May 2010
Research
Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
Figure 5

Figure 5. Age group–specific theoretical coverage of pneumococcal conjugate vaccines during the preimplementation and postimplementation periods of 7-valent pneumococcal conjugate vaccine (PCV-7), the Netherlands. IPD, invasive pneumococcal disease; PCV-10/PCV13, additional coverage by PCV-10 and PCV-13; PCV-13, additional coverage by PCV-13 alone; pre, preimplementation period (June 2004–June 2006); post, postimplementation period (June 2006–June 2008).
Lessons from the History of Quarantine, from Plague to Influenza A
Length: 23:11





